Bioxyne Receives $1.7m Funding from Scottish Government Agency for UK Medicinal Cannabis Manufacturing Facility

Press Release Bioxyne (ASX: BXN) subsidiary Breathe Life Sciences UK has received approximately $1.7 million in funding from economic development agency South of Scotland Enterprise (SOSE) to establish its UK medicinal cannabis manufacturing and distribution facility. ++Bioxyne (ASX: BXN)++ subsidiary Breathe Life Sciences UK has received approximately $1.7 million in funding from economic development agency […]